January 31st, 2022
•Drug-induced liver injury (DILI) is a major cause of drug failure. A protocol has been developed to accurately predict the DILI liability of a compound using a liver microphysiological system (MPS). The liver model uses the coculture of primary hepatic cells and translationally relevant endpoints to assess cellular responses to treatment.
Related Videos
In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Isolation of Rat Portal Fibroblasts by In situ Liver Perfusion
Long-term Lethal Toxicity Test with the Crustacean Artemia franciscana
Do-It-Yourself Device for Recovery of Cryopreserved Samples Accidentally Dropped into Cryogenic Storage Tanks
Isolation of Human Hepatocytes by a Two-step Collagenase Perfusion Procedure
A Protocol for Lentiviral Transduction and Downstream Analysis of Intestinal Organoids
Protocol for Isolation of Primary Human Hepatocytes and Corresponding Major Populations of Non-parenchymal Liver Cells
Experimental Protocol for Using Drosophila As an Invertebrate Model System for Toxicity Testing in the Laboratory
Cell Type-specific Gene Expression Profiling in the Mouse Liver
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved